Austrian Researchers Identify Target for Treatment of Multiple Sclerosis
Multiple sclerosis is the most common disease of the CNS in young adults. Researchers may…
Get the latest biotech Austria news. Learn more about the latest regulations, collaboration deals, and technology advancements of biotech companies in Austria.
Multiple sclerosis is the most common disease of the CNS in young adults. Researchers may…
An alternative approach for the repair of broken bones is being developed in Austria, which…
The novel antibiotic lefamulin brought home late-stage success to Nabriva by proving itself to be on…
UPDATE (05/09/2017): Innovate UK has granted Themis £3M (€3.3M) to push its Chikungunya Vaccine towards…
Apeiron Biologics has been granted financing of €25M from the European Investment Bank (EIB) to…
Tropical diseases are often neglected until an outbreak causes worldwide panic. Here’s how European biotech…
Immunotherapies have been taking the biotech world by storm. Among these are cancer vaccines, which…
Researchers from Austria and the UK have made new advances in engineering brain-like structures. These…
Update (08/05/2017): The European Commission has granted marketing authorization to Apeiron Biologic's APN311 in the…
Hookipa has presented positive data from its first Phase I trial testing its vaccine technology…
According to a new study, a phenomenon known as biased inheritance protects older bacteria from…
Curetis has launched Ares Genetics, a company that will use the biggest antibiotic resistance genetic database…